Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 37.86%
March 31, 2026 25.61%
December 31, 2025 40.32%
September 30, 2025 15.44%
June 30, 2025 36.74%
March 31, 2025 26.05%
December 31, 2024 35.35%
September 30, 2024 31.35%
June 30, 2024 43.52%
March 31, 2024 -119.3%
December 31, 2023 54.98%
September 30, 2023 -191.8%
June 30, 2023 -15.28%
March 31, 2023 -81.52%
December 31, 2022 -121.4%
Date Value
September 30, 2022 -220.9%
June 30, 2022 -51.62%
March 31, 2022 -14.30K%
December 31, 2021 -334.8%
September 30, 2021 -817.4%
June 30, 2021 -48.54%
March 31, 2021 -745.8%
December 31, 2020 -38.27%
September 30, 2020 -1.18K%
June 30, 2020 -344.1%
March 31, 2020 -225.0%
December 31, 2019 -75.40%
September 30, 2019 -6.25%
June 30, 2019 -62.50%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Omnicell, Inc. 48.98%
Alpha Tau Medical Ltd. --
Carlsmed, Inc. 76.78%
Vaso Corp. 79.46%
Global Innovative Platforms, Inc. 76.53%

Gross Profit Margin (Quarterly) Related Metrics